1. Comprehensive summary: the role of PBX1 in development and cancers.
- Author
-
Mingsheng Liu, Yan Xing, Jiufeng Tan, Xiaoliang Chen, Yaming Xue, Licheng Qu, Jianchao Ma, and Xuefei Jin
- Subjects
TRANSCRIPTION factors ,HOMEOBOX proteins ,DRUG development ,HEMATOLOGIC malignancies ,LYMPHOBLASTIC leukemia - Abstract
PBX1 is a transcription factor that can promote the occurrence of various tumors and play a reg-ulatory role in tumor growth, metastasis, invasion, and drug resistance. Furthermore, a variant generated by fusion of E2A and PBX1, E2A-PBX1, has been found in 25% of patients with childhood acute lymphoblastic leukemia. Thus, PBX1 is a potential therapeutic target for many cancers. Here, we describe the structure of PBX1 and E2A-PBX1 as well as the molecular mecha-nisms whereby these proteins promote tumorigenesis to provide future research directions for developing new treatments. We show that PBX1 and E2A-PBX1 induce the development of highly malignant and difficult-to-treat solid and blood tumors. The development of specific drugs against their targets may be a good therapeutic strategy for PBX1-related cancers. Furthermore, we strongly recommend E2A-PBX1 as one of the genes for prenatal screening to reduce the incidence of childhood hematological malignancies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF